Auditory and Vestibular Complaints Among COVID-19 Patients: A Descriptive Survey of 300 Young Patients Over a 3-Month Follow-up Period
Abstract
Introduction: COVID-19 is a pandemic disease caused by a novel coronavirus, presenting a wide range of symptoms. Most of the reported symptoms are commonly related to the respiratory system; however, over time, the disease has shown new diverse signs and symptoms. Recent studies have suggested that COVID-19 may affect the auditory and vestibular systems. Besides, little is known about symptoms that persist after the recovery. This study aimed to investigate the general characteristics and especially auditory and vestibular symptoms in young COVID-19 patients over a 3-month follow-up.
Materials and Methods: A total of 300 participants aged 25-45 years took part in this cohort study. They were diagnosed with COVID-19, according to radiographical abnormalities on CT scan and or PCR test, and were in good health based on medical history. Patients who had a history of hearing loss, vertigo, tinnitus, or any disease associated with auditory and vestibular disorders and who were hospitalized and received drugs were excluded. We collected patients’ demographics, some common symptoms, and their complaints (acute phase), and 1 month and 3 months later (follow-up phases) using a checklist of symptoms. The participants were asked to describe their chief complaints and, in particular, whether they had any complaints of hearing problems, tinnitus, rotatory vertigo, and aural fullness, or even changes in these symptoms over these periods.
Results: Auditory and vestibular symptoms were observed in a small percentage of COVID-19 patients and were not their chief complaints. Overall, among 300 patients, only about 5% of patients (15 cases) expressed rotatory vertigo, 4% (12 cases) aural fullness, 2.66% (8 cases) tinnitus, and 2.66% (8 cases) hearing problem in the acute phase. However, these symptoms disappeared almost in all participants in the follow-up phases (0 to 3 cases). In addition, none of these symptoms were the patients’ chief complaints.
Conclusion: Only a small percentage of COVID-19 patients complained of auditory and vestibular symptoms. It needs to be determined whether these complaints are due to the effects of the virus itself, medications, or stress. The persistence of some symptoms, such as fatigue even after 3 months, indicates the long-term impact of the COVID-19 virus, which necessitates further studies.
Sriwijitalai W, Wjwanitkit V. Hearing loss and COVID-19: A note. American Journal of Otolaryngology. 2021; 41(3):102473. [DOI:10.1016/j.amjoto.2020.102473] [PMID] [PMCID]
Saniasiaya J. Hearing loss in SARS-CoV-2: What do we know? Ear, Nose & Throat Journal. 2021; 100(2_suppl):152S-4S. [DOI:10.1177/0145561320946902] [PMID] [PMCID]
Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, Chang J, et al. Neurologic manifestations of hospitalized patients with Coronavirus disease 2019 in Wuhan, China. JAMA Neurology. 2020; 77(6):683-90. [PMID]
Gupta I, Reddy MK, Hussain MM, Murthy PM, Robert CA. Atypical neurological manifestations of COVID-19. Cureus. 2020; 12(6):e8518. [DOI:10.7759/cureus.8518] [PMID]
Fidan V. New type of corona virus induced acute otitis media in adult. American Journal of Otolaryngology. 2020; 41(3):102487. [DOI:10.1016/j.amjoto.2020.102487] [PMID] [PMCID]
Karimi-Galougahi M, Naeini AS, Raad N, Mikaniki N, Ghorbani J. Vertigo and hearing loss during the COVID-19pandemic-is there an association? Acta Otorhinolaryngologica Italica. 2020; 40(6):463-5. [PMID]
Degen CV, Lenarz T, Willenborf K. Acute profound sensorineural hearing loss after COVID-19pneumonia. Mayo Clinic Proceedings. 2020; 95(8):1801-3. [DOI:10.1016/j.mayocp.2020.05.034] [PMID] [PMCID]
Mustafa MWM. Audiological profile of asymptomatic Covid-19 PCR-positive cases. American Journal of Otolaryngology. 2020; 41(3):102483. [DOI:10.1016/j.amjoto.2020.102483] [PMID] [PMCID]
Kilic O, Kalcioglu MT, Cag Y, Tuysuz O, Pektas E, Caskurlu H, et al. Could sudden sensorineural hearing loss be the sole manifestation of COVID-19-19? An investigationinto SARS-COV-2 in the etiology of sudden sensorineural hearing loss. International Journal of Infectious Diseases. 2020; 97:208-11. [DOI:10.1016/j.ijid.2020.06.023] [PMID] [PMCID]
Sun R, Liu H, Wang X. Mediastinal emphysema, giant bulla, and pneumothorax developed during the course of COVID-19 pneumonia. Korean Journal of Radiology. 2020; 21(5):541-4. [DOI:10.3348/kjr.2020.0180] [PMID] [PMCID]
Abdel Rhman S, Abdel Wahid A. COVID-19 -19 and sudden sensorineural hearing loss, a case report. Otolaryngology Case Reports. 2020; 16:100198. [DOI:10.1016/j.xocr.2020.100198] [PMCID]
Cui C, Yao Q, Zhang D, Zhao Y, Zhang K, Nisenbaum E, et al. Approaching otolaryngology patients during the COVID-19-pandemic. Otolaryngology--Head and Neck Surgery. 2020; 163(1):121-31. [DOI:10.1177/0194599820926144] [PMID] [PMCID]
Lechien JR, Chiesa-Estomba CM, Place S, Van Laethem Y, Cabaraux P, Mat Q, et al. Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate coronavirus disease 2019. Journal of Internal Medicine. 2020; 288(3):335-44. [PMID]
Han W, Quan B, Guo Y, Zhang J, Lu Y, Feng G, et al. The course of clinical diagnosis and treatment of a case infected with coronavirus disease 2019. Journal of Medical Virology. 2020; 92(5):461-3. [DOI:10.1002/jmv.25711] [PMID] [PMCID]
Elibol E. Otolaryngological symptoms in COVID-19. European Archives of Oto-Rhino-Laryngology. 2021; 278(4):1233-6. [DOI:10.1007/s00405-020-06319-7] [PMID] [PMCID]
Özçelik Korkmaz M, Eğilmez OK, Özçelik MA, Güven M. Otolaryngological manifestations of hospitalised patients with confirmed COVID-19 infection. European Archives of Oto-Rhino-Laryngology. 2021; 278(5):1675-85. [DOI:10.1007/s00405-020-06396-8] [PMID] [PMCID]
Wege H, Watanabe R, ter Meulen V. Relapsing subacute demyelinating encephalomyelitis in eats during the course of coronavirus JHM infection. Journal of Neuroimmunology. 1984; 6(5):325-36 [DOI:10.1016/0165-5728(84)90022-5] [PMID]
Wong V. A neurophysiological study in children with Miller Fisher syndrome and Guillain-Barre syndrome. Brain & Development. 1997;19(3):197-204. [DOI:10.1016/S0387-7604(96)00554-2] [PMID]
Rahimi V, Asiyabar MK, Rouhbakhsh N. Sudden hearing loss and coronavirus disease 2019: The role of corticosteroid intra-tympanic injection in hearing improvement. The Journal of Laryngology & Otology. 2021; 135(5):464-6. [DOI:10.1017/S0022215121001080] [PMID]
Tavanai E, Mohammadkhani G. A different view on the link between tinnitus and cognition; is there a reciprocal link? The International Journal of Neuroscience. 2018; 128(12):1188-98. [PMID]
Chung SD, Hung SH, Lin HC, Sheu JJ. Association between sudden sensorineural hearing loss and anxiety disorder: A population-based study. European Archives of Oto-Rhino-Laryngology. 2015; 272(10):2673-8 [DOI:10.1007/s00405-014-3235-8] [PMID]
Monzani D, Casolari L, Guidetti G, Rigatelli M. Psychological distress and disability in patients with vertigo. Journal of Psychosomatic Research. 2001; 50(6):319-23. [DOI:10.1016/S0022-3999(01)00208-2] [PMID]
Almufarrij I, Uus K, Munro KJ. Does coronavirus affect the audio-vestibular system? A rapid systematic review. International Journal of Audiology. 2020; 59(7):487-91. [PMID]
Ciorba A, Corazzi V, Skarżyński PH, Skarżyńska MB, Bianchini C, Pelucchi S, et al. Don’t forget ototoxicity during the SARS-CoV-2 (COVID-19) pandemic! International Journal of Immunopathology and Pharmacology. 2020; 34:2058738420941754. [DOI:10.1177/2058738420941754] [PMID] [PMCID]
Bortoli R, Santiago M. Chloroquine ototoxicity. Clinical Rheumatology. 2007; 26(11):1809-10. [DOI:10.1007/s10067-007-0662-6] [PMID]
Prayuenyong P, Kasbekar AV, Baguley DM. Clinical implications of chloroquine and hydroxychloroquine ototoxicity for COVID-19-19 treatment: A mini-review. Frontiers in Public Health. 2020; 8:252. [DOI:10.3389/fpubh.2020.00252] [PMID] [PMCID]
Skarzynska MB, Krol B, Czajka N, Czajka L. Ototoxicity of drugs used in the treatment of covid-19. Journal of Hearing Science. 2020; 10(1):9-20. [DOI:10.17430/JHS.2020.10.1.1]
Seçkin U, Ozoran K, Ikinciogullari A, Borman P, Bostan EE. Hydroxychloroquine ototoxicity in a patient with rheumatoid arthritis. Rheumatology International. 2000; 19(5):203-4. [DOI:10.1007/s002960000054] [PMID]
| Files | ||
| Issue | Vol 16 No 1 (2022) | |
| Section | Research Article(s) | |
| DOI | https://doi.org/10.18502/jmr.v16i1.8564 | |
| Keywords | ||
| COVID-19 virus, Auditory, Vestibular | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
